908 Devices (MASS) Invested Capital (2020 - 2026)

908 Devices (MASS) posted quarterly Invested Capital of $22.4 million for Q1 2026, up 39.82% quarter-over-quarter from $16.0 million in Q4 2025.

908 Devices (MASS) Invested Capital (2020 - 2026) Analysis & Trends

908 Devices (MASS) has reported Invested Capital for 6 consecutive years, with $22.4 million the latest figure, recorded in Q1 2026.

In Q1 2026, Invested Capital changed N/A year-over-year to $22.4 million; the TTM figure through Mar 2026 stood at $73.0 million (changed N/A YoY), while the FY2025 annual figure was $16.0 million, changed N/A from the prior year.
Invested Capital grew to $22.4 million in Q1 2026 per MASS's latest filing, from $16.0 million in the prior quarter.
Across five years, Invested Capital topped out at $23.0 million in Q3 2025 and bottomed at $500000.0 in Q4 2023.
Historically, Invested Capital has averaged $10.1 million across 4 years, with a median of $11.6 million in 2025.
Annual changes were most pronounced in 2022 — Invested Capital changed 0.0% — and 2023, when it tumbled 96.67%.
908 Devices' Invested Capital stood at $15.0 million in 2022, then slumped by 96.67% to $500000.0 in 2023, then surged by 3105.0% to $16.0 million in 2025, then soared by 39.82% to $22.4 million in 2026.
Business Quant data shows MASS's Invested Capital at $22.4 million in Q1 2026, $16.0 million in Q4 2025, and $23.0 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	3.01 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	750.00 Mn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	1.71 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	2.00 Mn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	1.34 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	243.40 Mn
10	908 Devices	387.65 Mn	286.12 Mn	8.34 Mn	27.96 Mn

Download Data